Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1000804

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update


Lunar, Maja; Židovec Lepej, Snježana; Tomazic, Janez; Vovko, Tomaz D; Pecavar, Blaž; Turel, Gabriele; Maver, Manja; Poljak, Mario
HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update // PLoS One, 13 (2018), 4; e0196670-e0196670 doi:10.1371/journal.pone.0196670 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1000804 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update

Autori
Lunar, Maja ; Židovec Lepej, Snježana ; Tomazic, Janez ; Vovko, Tomaz D ; Pecavar, Blaž ; Turel, Gabriele ; Maver, Manja ; Poljak, Mario

Izvornik
PLoS One (1932-6203) 13 (2018), 4; E0196670-e0196670

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
non-B subtypes ; naive patients ; prevalence ; europe ; epidemiology ; transmission ; performance ; population ; sequences ; Greece

Sažetak
HIV-positive individuals that have a detected transmitted drug resistance (TDR) at baseline have a higher risk of virological failure with antiretroviral therapy (ART). This study offers an update on the prevalence of TDR in Slovenia, looks for onward transmission of TDR, and reassesses the need for baseline drug resistance testing. Blinded questionnaires and partial pol sequences were obtained from 54.5% (168/308) of all of the patients diagnosed with HIV-1 from 2011 to 2016. Subtype B was detected in 82.7% (139/168) of patients, followed by subtype A (8.3%), subtype C (2.4%), and CRF01_AE (1.8%). Surveillance drug resistance mutations (SDRMs) were found in four individuals (2.4%), all of them men who have sex with men (MSM) and infected with subtype B. K103N was detected in two patients and T68D and T215D in one person each, corresponding to a prevalence of 0%, 1.2%, and 1.2% of TDR to protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), and non-NRTIs (NNRTIs), respectively. The impact of mutations on drug susceptibility was found to be most pronounced for NNRTIs. No forward spread of TDR within the country was observed ; however, phylogenetic analysis revealed several new introductions of HIV into Slovenia in recent years, possibly due to increased risky behavior by MSM. This was indirectly confirmed by a substantial increase in syphilis cases and HIV-1 non-B sub-types during the study period. A drug-resistant HIV variant with good transmission fitness is thus more likely to be imported into Slovenia in the near future, and so TDR should be closely monitored.

Izvorni jezik
Engleski



POVEZANOST RADA


Projekti:
143-1080116-0097 - Imunološka rekonstitucija i rezistencija na lijekove u HIV-bolesnika iz Hrvatske (Židovec-Lepej, Snježana, MZOS ) ( CroRIS)

Ustanove:
Klinika za infektivne bolesti "Dr Fran Mihaljević"

Profili:

Avatar Url Snježana Židovec-Lepej (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Lunar, Maja; Židovec Lepej, Snježana; Tomazic, Janez; Vovko, Tomaz D; Pecavar, Blaž; Turel, Gabriele; Maver, Manja; Poljak, Mario
HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update // PLoS One, 13 (2018), 4; e0196670-e0196670 doi:10.1371/journal.pone.0196670 (međunarodna recenzija, članak, znanstveni)
Lunar, M., Židovec Lepej, S., Tomazic, J., Vovko, T., Pecavar, B., Turel, G., Maver, M. & Poljak, M. (2018) HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update. PLoS One, 13 (4), e0196670-e0196670 doi:10.1371/journal.pone.0196670.
@article{article, author = {Lunar, Maja and \v{Z}idovec Lepej, Snje\v{z}ana and Tomazic, Janez and Vovko, Tomaz D and Pecavar, Bla\v{z} and Turel, Gabriele and Maver, Manja and Poljak, Mario}, year = {2018}, pages = {e0196670-e0196670}, DOI = {10.1371/journal.pone.0196670}, keywords = {non-B subtypes, naive patients, prevalence, europe, epidemiology, transmission, performance, population, sequences, Greece}, journal = {PLoS One}, doi = {10.1371/journal.pone.0196670}, volume = {13}, number = {4}, issn = {1932-6203}, title = {HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update}, keyword = {non-B subtypes, naive patients, prevalence, europe, epidemiology, transmission, performance, population, sequences, Greece} }
@article{article, author = {Lunar, Maja and \v{Z}idovec Lepej, Snje\v{z}ana and Tomazic, Janez and Vovko, Tomaz D and Pecavar, Bla\v{z} and Turel, Gabriele and Maver, Manja and Poljak, Mario}, year = {2018}, pages = {e0196670-e0196670}, DOI = {10.1371/journal.pone.0196670}, keywords = {non-B subtypes, naive patients, prevalence, europe, epidemiology, transmission, performance, population, sequences, Greece}, journal = {PLoS One}, doi = {10.1371/journal.pone.0196670}, volume = {13}, number = {4}, issn = {1932-6203}, title = {HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update}, keyword = {non-B subtypes, naive patients, prevalence, europe, epidemiology, transmission, performance, population, sequences, Greece} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font